Medical devices, healthcare technology and the business of care
510(k) clearance · K261261

Dura-Arch

Hangzhou SHINING3D Dental Technology Co., Ltd. · Decision date Apr 17, 2026

FDA DECISIONK261261

What did the FDA decide?

FDA records K261261 as a 510(k) premarket notification, with a decision dated Apr 17, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Dental
Decision date
Apr 17, 2026

FDA source record

Regulatory record facts

Identifier
K261261
Regulatory pathway
510(k) premarket notification
Product code
EBG
Decision code
SESE
Decision date
Apr 17, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Crown And Bridge, Temporary, Resin.

Product code
EBG
FDA device class
2

FDA decision timeline

  1. K261261 received

    Application receipt date recorded by FDA.

  2. K261261 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code EBG

Product / regulatory recordCompanyPathwayDecision dateSource
Ezi-CrownK263004
MEDICLUS510(k) clearanceNov 3, 2026FDA
Liaoning Upcera Co., Ltd.510(k) clearanceMar 2, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Hangzhou SHINING3D Dental Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Hangzhou

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records